Orlando Berges
Analyst · Sandler O'Neill. Please go ahead
Good morning, everyone. So Aurelio mentioned the first quarter results reflected net income of $25.6 million or $0.12 a shares which compares to $333 million last quarter – you remember, last quarter results include the partial reversal of the deferred tax asset evaluation allowance which is shown as a credit, so we recover that context expense line, and that obviously affects the comparability, moreover to mention that since the evaluation allowance has been reverse fortified, we are now require to be at good income tax expense calculation on current earnings, that must not mean that the actual payments are going to be the same amount but for GAAP purposes now we're going to be showing income tax expense going forward. So for this quarter I think it's better to compare pretax income which amounted to $33.7 million in the quarter versus $31.9 million last quarter. In this quarter results, the bucketed side showed a $13.4 million margin scheme from the development section which I will explain a little bit in more detail. We also saw increases of $1.4 million in non-interest income and reduction of $1.9 million in expenses. That net of $2.1 million exactly in expenses related to conversion and contract cost on the Doral volumes. On the other hand, net interest income for the quarter is down $3.5 million, I am also going to detail, and the probation for the quarter which is $9 million higher than last quarter. The increase in the provision, it's a number of factors; on the commercial side we had $10.6 million more provision which reflects migration of certain commercial loans to worse loan classification and some increases on some of the specific returns on in parallels. But also we had much higher recoveries on the fourth quarter of last year, we had $4.7 million in commercial recoveries as compared to $1 million this quarter. The residential and mortgage slide also shows $1.5 million increase in probation, that's main two components in the provisional with a higher portfolio. And we also had some impact in the general research related to operate volume reductions that we saw over the year. On the other hand, the consumer portfolios are behaving much better and we had $4 million decrease in the portfolio primarily on loss rating from the order portfolio than that went down [ph]. On the chart, if you look at the results, for the quarter we had the acquisition as our development of the [indiscernible] for Doral. Therefore $221 million in residential mortgage loans, 9% during that – we also acquired some $3.8 million in other consumer loans and ordered rough lines also at a discount. This will also – this loan preferred value at $311 million, spot of the accounting, we also acquired $522 million in deposits, we paid out 1.6% premium, you remember from the filing data earlier in the quarter, we booked 40% intangible $5.8 million related to those deposits. The net impact of this transaction in terms of per value of the assets is offered in a $13.4 million bargain purchasing – pretax bargain purchasing gain. Also the result include $2.1 million as I mentioned in non-recurring transaction and conversion cost. Important to mention, however that there will some more insurance conversion cost that will be incurred in the second quarter that not just reflected additional base. And also the expense categories include our $1.1 million of income services cost which basically departs through over singular expenses. Once we complete conversions that should happen in this second quarter, this cost will all be replaced by parallel internal processing costs which will be much lower than this interim servicing. Excluding Doral, you have seen this charge of pretax earnings for the quarter were $22.7 million or $0.09 a share which seasonal at $6.7 million lower than last quarter, that was again driven by the higher provisions, $8.5 million higher provision. Also, last quarter you might remember we had $2.5 million late quarter cancellation penalty on our loan that was paid off at the end of December, that went into interest income, so that increased the net interest income component in the fourth quarter of 2014. On the other hand, expenses were $5.8 million excluding Doral, lower than last quarter and we'll touch upon those components later on on expense chart. Net interest income, important where declines $3.5 million on the hold entity including Doral, just $3.5 million, we not showing that interest income does reflect the $2.5 million impact that we had on the prepayment on the last quarter. If we exclude that net interest income decrease by $700,000 as compared to last quarter. Net interest margin on a GAAP basis was flat but we had just – the margin last quarter for the $2.5 million component I just mentioned and some other derivatives, reality [ph] margin going on from 409 to 418 for the quarter, not related with the acquired assets. What we had in the quarter, we had $1.4 million decrease related to these, there were two less rate in the quarter as compared to last quarter, and we had $2.9 million decrease related to volumes, we had real options in the average volume as both of the commercial and the consumer portfolio. On the other hand, we had $1.6 million in interest income associated with residential mortgage loans acquired on the Doral transaction, and we had increases of $400,000 on mortgage backed securities that we have in the investment portfolio. On the funding side, interest expense associated with the deposit accounts went down $1 million, that is with reassessment of interest rates that we had on savings and check in accounts and option in size of the broker city portfolio. We also had some reductions in $81,000 in interest expense related to restructuring of $400 million related over the quarter. Overall, the cause of our interest average core deposits went down 4 basis points as well as the cost of all deposits, they went down 4 basis points and that's a function of continued deposit cost structure based on own market. Again, as Aurelio mentioned before, our focus remains on growing non-broker deposits and improving the overall funding mix. This quarter we used some of the excess cash from the brokerage section to pay up brokerage and that portfolio was reduced by $250 million as we get to December balances. Looking at the net interest income components, excluding the bargain purchase scheme, net interest income component was $17.9 million, and that include – that reflects an increase of $1.4 million from last quarter – I'm sorry, the $17.9 million was last quarter, this quarter was $19.3 million. $1.5 million of the average insurance commissions, these are seasonal components that are on the commissions we think by net insurance agency. And we also had $700,000 pick up on fee income associated with all the deposit accounts acquired from Doral. On the other hand, we had longer gains on sales of mortgage portfolios on the secondary market sales as well as reputations [ph] which offset some of those income. Expenses are worth really good in the quarter, non-interest expenses in the quarter amounted to $91.7 million, a decrease of $2 million from last quarter. That includes the $2.1 million related to acquisition and from section cost rate to allow. It means that non-interest expenses decreased $4 million, main drivers; credit related expenses are down $1.8 million; that is a function above additional implementation of the industry alike from the disposition of arrears this quarter, as well as reduction in professional fees related to the legal services collection fees and troubled by longer solutions as compared to the last quarter. Occupancy expenses are down, about $500,000 and that is after including our $200,000 of ongoing expenses associated with Doral. Of these item, although taxes are down $1.5 million, and that's the elimination of the Puerto Rico national gross receipt tax which was the factory buses generate first, that was – on average was $1.5 million per quarter. Also we've seen the continuing decrease on BAC insurance cost, it's down $900,000 this quarter and that's a function of improvements in the many categories, this quarter obviously higher liquidity, with auction of broker CDs and continuation of the earnings. Business promotion is down $1.8 billion, there is a lot of seasonality there in terms of campaign, so that's a not necessarily ongoing on quarters but we did see that on this first quarter. On the other hand, if you look at employee compensation, it's up $1.8 million, that excludes the $300,000 associated with employees on the Doral branches, and also additional payroll factors on month's accrual as we started the mid-year. Important to mention that included in other expenses, the other expense line items here are – it's $1.1 million that I mentioned related to the past few loan service and interim loan servicing cost associated with the Doral manufacturing. This cost definitely will borrow in the future based on once we complete conversion. Moving towards the quality, Aurelio mentioned the key component, again, non-performing went up $37 million with reality mostly related to basically – all related to PREPA loan that was put in on accrual. If we exclude the PREPA loan, non-performing assets decrease by $37.4 million. Same thing the non-performing loans, they went up $39 million but excluding PREPA basically declined $35 million this quarter. One important components that we did see during auctions in inflows of non-performing – PREPA obviously, with PREPA inflows were $118 million, but total inflows went down to $43.7 million if we exclude the PREPA loan. We saw it treated in basically all categories, we have seen it down $8.5 million, CDR [ph] is down $4 million, consumer is down $5.7 million, so we saw reductions in plausible different loan categories except for that one facility. OREO balances are down $1.4 million, net impact of foreclosures and sales we have achieved in the quarter, and adversely classified commercial loans supporting naturally [ph] are down by $53 million which is a 10% reduction in that category. CDRs were $705 million at the end of March which is slightly up from – it's $10 million up from December, and now approximately $434 million of those were in accrual status. Net charge-offs behave very much in line with last quarter they were $29 million as compared to $27 million. The variance is mainly related to the recovery component, as I mentioned on the commercial side we had $4 million lower recoveries this month – I'm sorry, this quarter as compared to last quarter. The allowance at the end of March was 238 of loans compared to 240 at the end of December, even though all the allowances are bid by $3.6 million but this increase is obviously a function of the addition of 300 and plus 1 million portfolio that we acquired from Doral. The ratio of the allowance to non-performing loans was 40%, 40.1% as compared to 42.4% at the end of December. Net carry forward of non-performing commercial loans still are only 58%, $0.58 on the dollar, and as we have seen in the Basel III, it's been consistent. On the capital front, I would elaborate some comments already but just to mention that obviously Basel III rules began effective January 1, and they are subject to multi-year concession provisions primarily related to some of the items that are applied for retract inductions and adjustments. The Tier 1 total and average ratios on the Basel III as of March were 16.15%, 19.19% and 12.17% respectively. Those numbers on the Basel I rules were 18.44%, 19.70% and 13.27%. Important thing here to mention on the Basel III rules, the two significant changes we saw is one that was, the corporation has some cross preferred securities, 75% of those are no longer included in the Tier 1 calculation, they are included in total. And also there were some changes on definitions of risk weighted assets that affected the numbers. Keep in mind that there was some impact from the additional assets acquired on the development section. Also important, the Common Equity Tier 1 capital, the Basel III 2015-16 which is a strong ratio, and as Aurelio mentioned, we completed our dephas process in the first quarter and submitted out results a bit later prior to the March 31 deadline, and we expect those to close severally under a supermation by the end of June. With that I'll open the call for questions. Thanks.